Meritage Portfolio Management Gilead Sciences, Inc. Transaction History
Meritage Portfolio Management
- $1.56 Billion
- Q4 2024
A detailed history of Meritage Portfolio Management transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Meritage Portfolio Management holds 54,876 shares of GILD stock, worth $5.81 Million. This represents 0.32% of its overall portfolio holdings.
Number of Shares
54,876
Previous 58,603
6.36%
Holding current value
$5.81 Million
Previous $4.91 Million
3.15%
% of portfolio
0.32%
Previous 0.3%
Shares
25 transactions
Others Institutions Holding GILD
# of Institutions
2,045Shares Held
1BCall Options Held
10MPut Options Held
9.05M-
Black Rock Inc. New York, NY121MShares$12.8 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$12.2 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$7.6 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.2MShares$6.38 Billion0.21% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$6.14 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $133B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...